D365 Finance & Operations Software Developer - Cambridge Isotope Laboratories, Inc.

Cambridge Isotope Laboratories, Inc. (CIL) is searching for a D365 F&O Software Developer based onsite in our Tewksbury, MA facility.  CIL is the global leading company in a highly technical, extremely fast-growing industry and is a critical supplier to several scientific and high technology markets.  CIL's growing customer base spans academia, pharmaceutical, medical diagnostic and semiconductor industries enabling collaborations with Nobel laureates, industry-leading scientists, and chemists. CIL partners with leading instrument manufacturers as well pioneering research groups that have expertise in product development and drive market growth. CIL is a subsidiary of the Otsuka Pharmaceutical Group and has had consistent growth for over 40 years.

The D365 F&O Software Developer is responsible for the efficient design and delivery of high-quality software solutions for Microsoft Dynamics 365 Finance & Operations (F&O) necessary to meet the company's needs.

Responsibilities

• Full lifecycle application development; Tailor software solutions, customizations, and enhancements to Microsoft D365 F&O
• Design and develop modifications and extensions to the standard Microsoft D365 applications and interfaces with ISV applications
• Develop high-quality code in a timely manner
• Investigate, analyze and replicate issues, and provide support to system users
• Perform testing and analysis for operational functionality of solutions, delivery of finished products, and associated implementation
• Perform tuning improvement on software as needed
• Participate in modifying and improving business solutions design
• Play a lead role in managing existing products in order to improve compliance, consistency, robustness and performance
• Lead approved R&D initiatives as required

Requirements

• Bachelor's degree in Computer Science or a relevant concentration
• Minimum of 2 years' of software development experience, preferably in a GMP pharmaceutical or chemical manufacturing environment strongly preferred
• Strong software development experience, ability to use development tools including Microsoft X++ and .NET to develop software on top of Microsoft Dynamics 365 F&O
• Strong database knowledge, in-depth understanding of MS SQL server and able to use Transact–SQL to develop stored procedures
• Must possess working knowledge of Microsoft Dynamics D365 F&O
• Ability to take a proactive approach to developing and enhancing systems and processes
• Flexibility to respond to varied priorities within the deadlines, working both independently and within a team to manage evolving processes at short notice
• Problem solver that approaches challenges in a methodical way and with high attention to detail and accuracy

Benefits

CIL and CIS offer a competitive salary and comprehensive benefits including generous paid time off, Long Term Incentives, 6% matching 401K plan and health insurance with no in-network deductible.

CIL is an EEO/Affirmative Action employer.

Learn more about us on our website: www.isotope.com

About Us:

Cambridge Isotope Laboratories, Inc. (CIL) is the world’s leading producer of stable isotopes and stable isotope-labeled compounds. With approximately 750 employees and laboratories in four countries, CIL specializes in the process of labeling biochemical and organic compounds with highly enriched, stable (nonradioactive) isotopes of carbon, hydrogen, nitrogen and oxygen. Our chemists substitute common atoms (e.g., 1H, 12C, 14N, 16O) with rare, highly valued isotopes (e.g., 2H or D, 13C, 15N, 18O) so that the final product can be readily measured or traced using mass spectrometry (MS) or nuclear magnetic resonance (NMR). CIL’s products are utilized in laboratories, medical, government and academic research centers and health care facilities worldwide.

We are proud that CIL products have contributed to medical advancements in cancer research, new-drug development, environmental analysis, and medical diagnostic research. In the past decade, as the fields of proteomics and metabolomics have developed as leading techniques for determining biomarkers for disease presence, progression and the monitoring of therapeutic response, CIL has worked closely with industry leaders and researchers to provide the stable isotope-labeled tools needed for improved quantitation and qualification of complex biological systems.

After decades of research, stable isotopes have found their place in an ever expanding commercial scale applications in pharmaceuticals, semiconductors, flat panel displays as well as other high technology fields specifically with deuterium oxide (D2O) and deuterium gases. Pharmaceutical companies have begun to investigate deuteration of molecules that may provide advantages over their existing nondeuterated counterparts. In addition, increasing research into the potential medical advantages of new deuterated drugs is also occurring. In high technology, deuterated organic molecules and deuterium gas are commonly used in the manufacturing of microelectronics and OLEDs, which contribute to the increased lifetime of the devices.

Learn more about us on our website: www.isotope.com